HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Drug Screening

Drug Screening (DS) is used in the ER for pre-employment testing and identifies the most commonly abused substances, such as cocaine, opiates, tranquillizers, sedatives-barbiturates, and hallucinogens. It is a method for determining the presence of one or more drugs of abuse, usually in urine, by "stat" methods, such as EMIT (enzyme-mediated immunologic technique), FPIA (fluorescence polarisation immunoassay). The first step in the procedure is to identify a condition or a therapeutic field with an unmet need. A "druggable" target is identified, and drug screening then begins. Molecules that can interact with the target and/or support the intended phenotypic response are found during drug screening.

Committee Members
Speaker at Drug Delivery Events - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events -  Andreas M Papas

Andreas M Papas

Antares Health Products, United States
PDDS 2025 Speakers
Speaker at Pharmaceutical Conference - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
Speaker at Drug Delivery Events - Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd, United Kingdom
Speaker at Pharmaceutical Conference - Srividya Narayanan

Srividya Narayanan

Northeastern University, United States
Speaker at Pharmaceutical Conference - Maria Richards Brown

Maria Richards Brown

University College London, United Kingdom
Speaker at Pharma Conferences - Rassa Pegahi

Rassa Pegahi

UPSA, France
Speaker at Drug Delivery Events - Hanieh Khalili

Hanieh Khalili

University of East London, United Kingdom

Submit your abstract Today

Watsapp